HOLUBIAK MYRON Z
Insider CIK 1199080 · BIOS Director · VTUS Director · CTXR Vice Chairman, Director, 10% owner · CTOR Secretary, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CTOR CITIUS ONCOLOGY, INC. | A Award | 2025-09-19 | 2025-12-01 | 850,000 | — | $0 | 850,000 | SEC↗ |
| CTOR CITIUS ONCOLOGY, INC. | A Award | 2025-09-19 | 2025-12-22 | 850,000 | — | $0 | 850,000 | SEC↗ |
| CTOR CITIUS ONCOLOGY, INC. | A Award | 2025-09-19 | 2025-09-23 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CTOR CITIUS ONCOLOGY, INC. | A Award | 2025-09-19 | 2025-09-23 | 850,000 | — | $0 | 850,000 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | D To issuer deriv | 2025-08-08 | 2025-08-12 | 22,344 | — | $0 | 0 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | D To issuer deriv | 2025-08-08 | 2025-08-12 | 31,373 | — | $0 | 0 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2025-08-08 | 2025-08-12 | 31,373 | — | $0 | 31,373 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2025-08-08 | 2025-08-12 | 22,344 | — | $0 | 22,344 | SEC↗ |
| CTOR CITIUS ONCOLOGY, INC. | A Award deriv | 2024-12-12 | 2024-12-16 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CTOR CITIUS ONCOLOGY, INC. | A Award deriv | 2024-12-12 | 2024-12-16 | 300,000 | — | $0 | 300,000 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2024-11-07 | 2024-11-12 | 75,000 | — | $0 | 75,000 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2024-11-07 | 2024-11-12 | 350,000 | — | $0 | 350,000 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | D To issuer deriv | 2024-09-25 | 2024-09-27 | 558,597 | — | $0 | 0 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2024-09-25 | 2024-09-27 | 558,597 | — | $0 | 558,597 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | D To issuer deriv | 2024-08-14 | 2024-09-27 | 784,314 | — | $0 | 0 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2024-08-14 | 2024-09-27 | 784,314 | — | $0 | 784,314 | SEC↗ |
| CTOR CITIUS ONCOLOGY, INC. | A Award deriv | 2024-08-12 | 2024-08-14 | 500,000 | — | $0 | 500,000 | SEC↗ |
| CTOR CITIUS ONCOLOGY, INC. | A Award deriv | 2024-08-12 | 2024-08-30 | 1,500,000 | — | $0 | 1,500,000 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | D To issuer deriv | 2024-04-03 | 2024-04-05 | 129,450 | — | $0 | 0 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2024-04-03 | 2024-04-05 | 129,450 | — | $0 | 129,450 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2023-10-10 | 2023-10-12 | 400,000 | — | $0 | 400,000 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2022-10-04 | 2022-10-06 | 400,000 | — | $0 | 400,000 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2021-10-11 | 2021-10-13 | 650,000 | — | $0 | 650,000 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2021-10-11 | 2021-10-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2021-07-22 | 2021-07-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2021-07-22 | 2021-07-26 | 300,000 | — | $0 | 300,000 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | A Award deriv | 2021-05-20 | 2021-05-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2020-10-06 | 2020-10-09 | 200,000 | — | $0 | 200,000 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | A Award deriv | 2020-06-11 | 2020-06-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2019-10-08 | 2019-10-10 | 175,000 | — | $0 | 175,000 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | P Buy deriv | 2019-09-27 | 2019-09-27 | 558,597 | — | $0 | 558,597 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | P Buy | 2019-09-27 | 2019-09-27 | 558,597 | $0.90 | $502.7K | 1,992,243 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | A Award deriv | 2019-05-17 | 2019-05-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | P Buy deriv | 2019-04-03 | 2019-04-05 | 129,450 | — | $0 | 129,450 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | P Buy | 2019-04-03 | 2019-04-05 | 129,450 | $1.55 | $200.6K | 1,433,646 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2018-09-04 | 2018-09-06 | 150,000 | — | $0 | 150,000 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2018-08-13 | 2018-08-15 | 784,314 | — | $0 | 784,314 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | P Buy | 2018-08-13 | 2018-08-15 | 784,314 | $1.28 | $1.00M | 1,304,196 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | A Award deriv | 2018-05-30 | 2018-06-01 | 7,500 | — | $0 | 7,500 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | P Buy | 2018-03-28 | 2018-03-29 | 2,915 | $3.09 | $9.0K | 519,882 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2017-09-15 | 2017-09-19 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | A Award deriv | 2017-06-01 | 2017-06-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | A Award deriv | 2016-06-02 | 2016-06-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BIOS BioScrip, Inc. | M Exercise deriv | 2016-05-31 | 2016-06-02 | 10,000 | — | $0 | 0 | SEC↗ |
| BIOS BioScrip, Inc. | D To issuer | 2016-05-31 | 2016-06-02 | 10,000 | $2.70 | $27.0K | 40,000 | SEC↗ |
| BIOS BioScrip, Inc. | M Exercise | 2016-05-31 | 2016-06-02 | 10,000 | — | $0 | 50,000 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | J Other deriv | 2016-03-30 | 2016-04-08 | 0 | — | $0 | 694,217 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | J Other | 2016-03-30 | 2016-04-08 | 7,754,497 | — | $0 | 7,754,497 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | A Award deriv | 2015-05-28 | 2015-06-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BIOS BioScrip, Inc. | A Award deriv | 2015-05-20 | 2015-05-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | A Award deriv | 2014-07-10 | 2015-04-15 | 64,000 | — | $0 | 64,000 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | A Award deriv | 2014-07-10 | 2014-10-07 | 64,000 | — | $0 | 64,000 | SEC↗ |
| VTUS ASSEMBLY BIOSCIENCES, INC. | A Award deriv | 2014-07-10 | 2014-07-14 | 64,000 | — | $0 | 64,000 | SEC↗ |
| VTUS ASSEMBLY BIOSCIENCES, INC. | D To issuer deriv | 2014-07-10 | 2014-07-14 | 2,000 | — | $0 | 0 | SEC↗ |
| VTUS ASSEMBLY BIOSCIENCES, INC. | D To issuer deriv | 2014-07-10 | 2014-07-14 | 2,000 | — | $0 | 0 | SEC↗ |
| VTUS ASSEMBLY BIOSCIENCES, INC. | D To issuer deriv | 2014-07-10 | 2014-07-14 | 7,000 | — | $0 | 0 | SEC↗ |
| BIOS BioScrip, Inc. | M Exercise deriv | 2014-06-16 | 2014-06-18 | 5,000 | — | $0 | 0 | SEC↗ |
| BIOS BioScrip, Inc. | S Sale | 2014-06-16 | 2014-06-18 | 5,000 | $7.94 | $39.7K | 40,000 | SEC↗ |
| BIOS BioScrip, Inc. | M Exercise | 2014-06-16 | 2014-06-18 | 5,000 | $5.33 | $26.6K | 45,000 | SEC↗ |
| BIOS BioScrip, Inc. | A Award | 2014-05-08 | 2014-05-12 | 10,000 | — | $0 | 40,000 | SEC↗ |
| BIOS BioScrip, Inc. | D To issuer | 2014-03-14 | 2014-03-17 | 10,000 | $7.23 | $72.3K | 20,000 | SEC↗ |
| BIOS BioScrip, Inc. | M Exercise deriv | 2013-07-19 | 2013-07-23 | 11,200 | — | $0 | 0 | SEC↗ |
| BIOS BioScrip, Inc. | M Exercise deriv | 2013-07-19 | 2013-07-23 | 20,000 | — | $0 | 0 | SEC↗ |
| BIOS BioScrip, Inc. | M Exercise | 2013-07-19 | 2013-07-23 | 20,000 | $6.61 | $132.2K | 50,000 | SEC↗ |
| BIOS BioScrip, Inc. | S Sale | 2013-07-19 | 2013-07-23 | 31,200 | $16.34 | $509.8K | 30,000 | SEC↗ |
| BIOS BioScrip, Inc. | M Exercise | 2013-07-19 | 2013-07-23 | 11,200 | $7.97 | $89.3K | 61,200 | SEC↗ |
| BIOS BioScrip, Inc. | A Award | 2013-05-07 | 2013-05-09 | 10,000 | — | $0 | 30,000 | SEC↗ |
| VTUS VENTRUS BIOSCIENCES INC | A Award deriv | 2013-03-06 | 2013-03-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BIOS BioScrip, Inc. | S Sale | 2012-12-14 | 2012-12-18 | 10,000 | $10.82 | $108.2K | 20,000 | SEC↗ |
| BIOS BioScrip, Inc. | M Exercise deriv | 2012-09-07 | 2012-09-10 | 1,200 | — | $0 | 0 | SEC↗ |
| BIOS BioScrip, Inc. | S Sale | 2012-09-07 | 2012-09-10 | 1,200 | $8.50 | $10.2K | 30,000 | SEC↗ |
| BIOS BioScrip, Inc. | M Exercise | 2012-09-07 | 2012-09-10 | 1,200 | $4.28 | $5.1K | 31,200 | SEC↗ |
| BIOS BioScrip, Inc. | M Exercise deriv | 2012-09-06 | 2012-09-10 | 8,400 | — | $0 | 1,200 | SEC↗ |
| BIOS BioScrip, Inc. | M Exercise | 2012-09-06 | 2012-09-10 | 8,400 | $4.28 | $36.0K | 38,400 | SEC↗ |
| BIOS BioScrip, Inc. | S Sale | 2012-09-06 | 2012-09-10 | 8,400 | $8.51 | $71.5K | 30,000 | SEC↗ |
| BIOS BioScrip, Inc. | M Exercise deriv | 2012-09-04 | 2012-09-05 | 100 | — | $0 | 9,600 | SEC↗ |
| BIOS BioScrip, Inc. | M Exercise | 2012-09-04 | 2012-09-05 | 100 | $4.28 | $428 | 30,100 | SEC↗ |
| BIOS BioScrip, Inc. | S Sale | 2012-09-04 | 2012-09-05 | 100 | $8.50 | $850 | 30,000 | SEC↗ |
| BIOS BioScrip, Inc. | M Exercise deriv | 2012-08-31 | 2012-09-05 | 2,800 | — | $0 | 0 | SEC↗ |
| BIOS BioScrip, Inc. | M Exercise deriv | 2012-08-31 | 2012-09-05 | 3,900 | — | $0 | 9,700 | SEC↗ |
| BIOS BioScrip, Inc. | M Exercise | 2012-08-31 | 2012-09-05 | 3,900 | $4.28 | $16.7K | 33,900 | SEC↗ |
| BIOS BioScrip, Inc. | M Exercise | 2012-08-31 | 2012-09-05 | 2,800 | $4.43 | $12.4K | 32,800 | SEC↗ |
| BIOS BioScrip, Inc. | S Sale | 2012-08-31 | 2012-09-05 | 3,900 | $8.51 | $33.2K | 30,000 | SEC↗ |
| BIOS BioScrip, Inc. | S Sale | 2012-08-31 | 2012-09-05 | 2,800 | $8.50 | $23.8K | 30,000 | SEC↗ |
| BIOS BioScrip, Inc. | A Award | 2012-05-07 | 2012-05-11 | 10,000 | $7.52 | $75.2K | 30,000 | SEC↗ |